(Q36291603)

English

Oxaliplatin in practice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

14 September 2020

Oxaliplatin in practice (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

organoplatinum compounds

1 reference

12 November 2019

colorectal neoplasm

1 reference

14 September 2020

ovarian neoplasm

1 reference

14 September 2020

1 reference

14 September 2020

1 reference

based on heuristic

inferred from abstract

author name string

Misset JL

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 June 1998

9 references

Europe PubMed Central

PMC publication ID

13 August 2017

13 March 2019

14 March 2019

21 March 2019

24 March 2019

3 April 2019

12 November 2019

29 May 2020

14 September 2020

British Journal of Cancer

9 references

Europe PubMed Central

PMC publication ID

13 August 2017

13 March 2019

14 March 2019

21 March 2019

24 March 2019

3 April 2019

12 November 2019

29 May 2020

14 September 2020

77 Suppl 4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

4-7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1998.428

0 references

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149889

30 September 2017

Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149889

30 September 2017

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149889

29 June 2018

Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149889

22 September 2018

In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9647612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of oxaliplatin in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9647612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of trans-1-diaminocyclohexane oxalato-platinum (l-OHP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/9647612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1998.428

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36291603&oldid=1645891660"